Product Code: ETC332689 | Publication Date: Aug 2022 | Updated Date: Jun 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Nigeria Meningococcal Vaccines Market includes vaccines that protect against meningococcal disease. This market is crucial for public health, preventing outbreaks of meningitis and other serious infections.
The meningococcal vaccines market in Nigeria is witnessing growth driven by efforts to control and prevent meningitis outbreaks, increasing public health awareness, and government immunization programs. Meningococcal vaccines, designed to protect against bacterial meningitis caused by Neisseria meningitidis, are essential for preventing meningitis epidemics, particularly in the meningitis belt of sub-Saharan Africa, which includes Nigeria. With Nigeria history of meningitis outbreaks and the devastating impact on public health and mortality rates, there`s a growing emphasis on meningococcal vaccination campaigns, routine immunization schedules, and vaccine procurement initiatives. Moreover, collaborations between government agencies, international organizations, and vaccine manufacturers are driving the availability and accessibility of meningococcal vaccines in Nigeria, further stimulating market growth.
In Nigeria, the meningococcal vaccines market faces challenges such as vaccine hesitancy, logistical constraints, and funding gaps. These challenges impede vaccination campaigns and increase the risk of meningococcal disease outbreaks, posing public health risks and hindering efforts to control infectious diseases in the country.
To prevent meningococcal disease outbreaks and protect public health, government policies in Nigeria may address the meningococcal vaccines market. Regulatory frameworks may include vaccination schedules, immunization campaigns, and surveillance systems to monitor disease prevalence and vaccine coverage rates. Additionally, the government may procure vaccines through international partnerships, support research initiatives on vaccine development and efficacy, and implement strategies to improve vaccine access and affordability for vulnerable populations. Moreover, the government may collaborate with global health organizations, pharmaceutical companies, and healthcare providers to strengthen Nigeria capacity for meningococcal disease prevention and control.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Meningococcal Vaccines Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Meningococcal Vaccines Market Revenues & Volume, 2020 & 2030F |
3.3 Nigeria Meningococcal Vaccines Market - Industry Life Cycle |
3.4 Nigeria Meningococcal Vaccines Market - Porter's Five Forces |
3.5 Nigeria Meningococcal Vaccines Market Revenues & Volume Share, By Product, 2020 & 2030F |
3.6 Nigeria Meningococcal Vaccines Market Revenues & Volume Share, By Age Group, 2020 & 2030F |
3.7 Nigeria Meningococcal Vaccines Market Revenues & Volume Share, By Distribution Channel, 2020 & 2030F |
4 Nigeria Meningococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Nigeria Meningococcal Vaccines Market Trends |
6 Nigeria Meningococcal Vaccines Market, By Types |
6.1 Nigeria Meningococcal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Product, 2020 - 2030F |
6.1.3 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2020 - 2030F |
6.1.4 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Conjugate, 2020 - 2030F |
6.2 Nigeria Meningococcal Vaccines Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Infants, 2020 - 2030F |
6.2.3 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Children, 2020 - 2030F |
6.2.4 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Adolescents & Young Adults, 2020 - 2030F |
6.2.5 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Adults, 2020 - 2030F |
6.3 Nigeria Meningococcal Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Pharmacies, 2020 - 2030F |
6.3.3 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Community Clinics, 2020 - 2030F |
6.3.4 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Public Health Agencies, 2020 - 2030F |
6.3.5 Nigeria Meningococcal Vaccines Market Revenues & Volume, By Others, 2020 - 2030F |
7 Nigeria Meningococcal Vaccines Market Import-Export Trade Statistics |
7.1 Nigeria Meningococcal Vaccines Market Export to Major Countries |
7.2 Nigeria Meningococcal Vaccines Market Imports from Major Countries |
8 Nigeria Meningococcal Vaccines Market Key Performance Indicators |
9 Nigeria Meningococcal Vaccines Market - Opportunity Assessment |
9.1 Nigeria Meningococcal Vaccines Market Opportunity Assessment, By Product, 2020 & 2030F |
9.2 Nigeria Meningococcal Vaccines Market Opportunity Assessment, By Age Group, 2020 & 2030F |
9.3 Nigeria Meningococcal Vaccines Market Opportunity Assessment, By Distribution Channel, 2020 & 2030F |
10 Nigeria Meningococcal Vaccines Market - Competitive Landscape |
10.1 Nigeria Meningococcal Vaccines Market Revenue Share, By Companies, 2023 |
10.2 Nigeria Meningococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |